ROXAND VILLOCH: Open Payments
NPI 1891300331 · FERN PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 37 payments from 18 companies in 2025. Trend: 2023 $998 · 2024 $1,199 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $121 |
| Novo Nordisk Inc | 4 | $98 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| ABBVIE INC. | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Exact Sciences Corporation | 2 | $49 |
| SHIELD THERAPEUTICS INC | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| C2N Diagnostics, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: MOUNJARO, Ozempic, TRELEGY ELLIPTA, ACCRUFER, UBRELVY, BREZTRI, VRAYLAR, JARDIANCE.
Industry payments across FL — which companies pay providers there.
